Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial

Objectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper extremity complications may be underreported. Meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Eva M. Zwaan, Elena S. Cheung, Alexander J. J. IJsselmuiden, Carlo A. J. Holtzer, Ton A. R. Schreuders, Marcel J. M Kofflard, J. Henk Coert
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Interventional Cardiology
Online Access:http://dx.doi.org/10.1155/2022/6858962
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562355168346112
author Eva M. Zwaan
Elena S. Cheung
Alexander J. J. IJsselmuiden
Carlo A. J. Holtzer
Ton A. R. Schreuders
Marcel J. M Kofflard
J. Henk Coert
author_facet Eva M. Zwaan
Elena S. Cheung
Alexander J. J. IJsselmuiden
Carlo A. J. Holtzer
Ton A. R. Schreuders
Marcel J. M Kofflard
J. Henk Coert
author_sort Eva M. Zwaan
collection DOAJ
description Objectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper extremity complications may be underreported. Methods. The ARCUS was designed as a prospective cohort study, including 502 consecutive patients admitted for PCI. Patients treated with transfemoral PCI (TF-PCI) acted as a control group. A composite score of physical examinations and questionnaires was used for determining UED. Clinical outcomes were monitored during six months of follow-up, with its primary endpoint at two weeks. Results. A total of 440 TR-PCI and 62 control patients were included. Complete case analysis (n = 330) at 2 weeks of follow-up showed that UED in the TR-PCI group was significantly higher than that in the TF-PCI group: 32.7% versus 13.9%, respectively (p=0.04). The three impaired variables most contributing to UED were impaired elbow extension, wrist flexion, and extension. Multivariate logistic regression showed that smokers were almost three times more likely to develop UED. Conclusions. This study demonstrates that UED seems to occur two times more in TR-PCI than in TF-PCI at 2 weeks of follow-up. However, no significant long-term difference or difference between the intervention arm and the contralateral arm was found at all timepoints.
format Article
id doaj-art-4c999dc010534e4b988a24e01674ea45
institution Kabale University
issn 1540-8183
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Interventional Cardiology
spelling doaj-art-4c999dc010534e4b988a24e01674ea452025-02-03T01:22:48ZengWileyJournal of Interventional Cardiology1540-81832022-01-01202210.1155/2022/6858962Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS TrialEva M. Zwaan0Elena S. Cheung1Alexander J. J. IJsselmuiden2Carlo A. J. Holtzer3Ton A. R. Schreuders4Marcel J. M Kofflard5J. Henk Coert6Department of Plastic Surgery and Reconstructive SurgeryDepartment of Plastic Surgery and Reconstructive SurgeryDepartment of CardiologyDepartment of Plastic Surgery and Hand SurgeryDepartment of Plastic Surgery and Reconstructive SurgeryDepartment of CardiologyDepartment of Plastic Surgery and Reconstructive SurgeryObjectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper extremity complications may be underreported. Methods. The ARCUS was designed as a prospective cohort study, including 502 consecutive patients admitted for PCI. Patients treated with transfemoral PCI (TF-PCI) acted as a control group. A composite score of physical examinations and questionnaires was used for determining UED. Clinical outcomes were monitored during six months of follow-up, with its primary endpoint at two weeks. Results. A total of 440 TR-PCI and 62 control patients were included. Complete case analysis (n = 330) at 2 weeks of follow-up showed that UED in the TR-PCI group was significantly higher than that in the TF-PCI group: 32.7% versus 13.9%, respectively (p=0.04). The three impaired variables most contributing to UED were impaired elbow extension, wrist flexion, and extension. Multivariate logistic regression showed that smokers were almost three times more likely to develop UED. Conclusions. This study demonstrates that UED seems to occur two times more in TR-PCI than in TF-PCI at 2 weeks of follow-up. However, no significant long-term difference or difference between the intervention arm and the contralateral arm was found at all timepoints.http://dx.doi.org/10.1155/2022/6858962
spellingShingle Eva M. Zwaan
Elena S. Cheung
Alexander J. J. IJsselmuiden
Carlo A. J. Holtzer
Ton A. R. Schreuders
Marcel J. M Kofflard
J. Henk Coert
Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
Journal of Interventional Cardiology
title Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_full Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_fullStr Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_full_unstemmed Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_short Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_sort upper extremity function following transradial percutaneous coronary intervention results of the arcus trial
url http://dx.doi.org/10.1155/2022/6858962
work_keys_str_mv AT evamzwaan upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT elenascheung upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT alexanderjjijsselmuiden upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT carloajholtzer upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT tonarschreuders upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT marceljmkofflard upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT jhenkcoert upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial